These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9200947)

  • 1. [Application of chimeric and humanized antibodies to autoimmune diseases therapy].
    Noguchi H
    Nihon Rinsho; 1997 Jun; 55(6):1549-56. PubMed ID: 9200947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal antibodies for treating autoimmune diseases].
    Takeno M; Sakane T
    Nihon Rinsho; 1997 Jun; 55(6):1543-8. PubMed ID: 9200946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human-murine chimeric CD4 monoclonal antibodies. A modern panacea for autoimmune disease?
    Riethmüller G; Deusch K; Sanders ME; Dalesandro MR; Kiefersauer S; Reiter C; Rieber EP
    Immunol Ser; 1993; 59():261-9. PubMed ID: 8461391
    [No Abstract]   [Full Text] [Related]  

  • 4. New monoclonal antibodies in renal transplantation.
    Vincenti F
    Minerva Urol Nefrol; 2003 Mar; 55(1):57-66. PubMed ID: 12773967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases.
    Perosa F; Scudeletti M; Imro MA; Dammacco F; Luccarelli G; Indiveri F
    Clin Exp Rheumatol; 1997; 15(2):201-10. PubMed ID: 9196876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal antibody therapy for rheumatoid arthritis].
    Ishii T; Saeki Y
    Nihon Rinsho; 2002 Mar; 60(3):551-5. PubMed ID: 11904972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic applications of anti-CD4 antibodies.
    Olive D; Mawas C
    Crit Rev Ther Drug Carrier Syst; 1993; 10(1):29-63. PubMed ID: 8472311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease.
    Aruffo A; Hollenbaugh D
    Curr Opin Immunol; 2001 Dec; 13(6):683-6. PubMed ID: 11677090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock.
    Suitters AJ; Foulkes R; Opal SM; Palardy JE; Emtage JS; Rolfe M; Stephens S; Morgan A; Holt AR; Chaplin LC
    J Exp Med; 1994 Mar; 179(3):849-56. PubMed ID: 8113678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies.
    Robak T; Robak E
    BioDrugs; 2011 Feb; 25(1):13-25. PubMed ID: 21090841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease.
    Riethmüller G; Rieber EP; Kiefersauer S; Prinz J; van der Lubbe P; Meiser B; Breedveld F; Eisenburg J; Krüger K; Deusch K
    Immunol Rev; 1992 Oct; 129():81-104. PubMed ID: 1464423
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4.
    Williams RO; Ghrayeb J; Feldmann M; Maini RN
    Immunology; 1995 Mar; 84(3):433-9. PubMed ID: 7751027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases.
    Willrich MA; Murray DL; Snyder MR
    Transl Res; 2015 Feb; 165(2):270-82. PubMed ID: 25305470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in rheumatoid arthritis].
    Sibilia J
    Med Sci (Paris); 2009 Dec; 25(12):1033-8. PubMed ID: 20035675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
    Sfikakis PP
    Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential clinical efficacy of anti-CD4 monoclonal antibodies in rat adjuvant arthritis is paralleled by differential influence on NF-kappaB binding activity and TNF-alpha secretion of T cells.
    Pohlers D; Schmidt-Weber CB; Franch A; Kuhlmann J; Bräuer R; Emmrich F; Kinne RW
    Arthritis Res; 2002; 4(3):184-9. PubMed ID: 12010568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal Antibodies: A Review.
    Singh S; Kumar NK; Dwiwedi P; Charan J; Kaur R; Sidhu P; Chugh VK
    Curr Clin Pharmacol; 2018; 13(2):85-99. PubMed ID: 28799485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic monoclonal antibodies in ophthalmology.
    Rodrigues EB; Farah ME; Maia M; Penha FM; Regatieri C; Melo GB; Pinheiro MM; Zanetti CR
    Prog Retin Eye Res; 2009 Mar; 28(2):117-44. PubMed ID: 19114125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of autoimmune disease with monoclonal anti-CD4 antibodies.
    Waldor MK
    Immunol Ser; 1989; 45():573-86. PubMed ID: 2577329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.